The median N-cadherin mRNA expression level was significantly lower in metastasized neuroblastoma tumors (stage 4 and 4S) when compared to localized tumors (stages 1, 2, and 3) (p =0.006) (9). The gene discussed is CDH2; the disease is neuroblastoma.